West Pharmaceutical Services, Inc.
corporate_fare Company Profile
West Pharmaceutical Services, Inc. (NYSE:WST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for WST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for WST spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- West 10-Q Details Q3 Beat: $874.5M Sales, $3.02 EPS, $685M Buyback
- West Pharma Beats Q3, Lifts FY26 EPS Guidance to $9.38-$9.48 and Sales to $3.41B-$3.42B
- West Pharma Lifts FY EPS Outlook to $9.38-$9.48 After Q3 Beat
- West Pharma Guides FY Adjusted EPS to $9.38-$9.48
- West Pharmaceutical Reports Strong Q2 Results, Details Cyber Incident Impact, and Boosts Share Buybacks
Financial Snapshot
Short Interest & Short Volume
2.34 days to coverFINRA reported short interest of 1,807,517 shares in WST as of the October 30, 2026 settlement, a 10.2% decrease from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 48.5% of WST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.